Related Experiment Video
Updated: Feb 27, 2026

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
Value of upper endoscopic biopsies in predicting medical refractoriness in pediatric patients with ulcerative colitis
Katrina J Sullivan1, Mike Wei2, Elizabeth Chernetsova2
1Department of Pathology, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada K1H 8L1.
Insights
Pediatric refractory ulcerative colitis (UC) patients show more upper gastrointestinal inflammation. Upper endoscopy findings may predict treatment response in children with severe UC.
Area of Science:
- Pediatric Gastroenterology
- Inflammatory Bowel Disease Research
- Gastrointestinal Pathology
Background:
- Refractory ulcerative colitis (UC) signifies severe disease unresponsive to standard medical therapy.
- Limited research exists on upper endoscopic microscopic findings in pediatric refractory UC.
- Assessing upper GI tract inflammation may offer insights into disease severity and treatment response.
Purpose of the Study:
- To investigate the correlation between upper endoscopic microscopic findings and refractory UC in pediatric patients.
- To compare active inflammation in the upper GI tract between refractory and non-refractory UC pediatric groups.
- To evaluate the diagnostic performance of upper GI biopsies in predicting refractory UC.
Main Methods:
- Retrospective review of medical records from a tertiary pediatric center (2000-2014).
- Comparison of upper GI endoscopic biopsies between refractory UC and non-refractory UC pediatric patients.
- Statistical analysis to determine significant differences and diagnostic performance (sensitivity, specificity).
Main Results:
- Significant differences observed in intraepithelial neutrophil infiltration and crypt/gland involvement in the antrum, body, and duodenum.
- Higher incidence of microabscesses in the stomach and duodenum of refractory UC patients.
- Moderate sensitivity (38-67%) and high specificity (81-100%) of upper GI tissues in predicting refractory UC.
Conclusions:
- Children with refractory UC exhibit increased active inflammation in the upper GI tract.
- Upper GI microscopic findings may serve as a predictor for treatment responsiveness in pediatric UC.
- Further investigation into upper GI pathology could refine management strategies for refractory pediatric UC.
Abstract:
Refractory ulcerative colitis (UC) occurs in patients who experience a severe disease manifestation that is unresponsive to medical therapy. The assessment of upper endoscopic microscopic findings and its correlation with refractory UC has not been fully studied in pediatric patients and is the focus of this study. Medical records of UC patients treated at a tertiary pediatric center between 2000 and 2014 were reviewed. Endoscopic biopsies of the upper gastrointestinal (GI) tract of patients meeting a priori inclusion criteria were compared between refractory UC patients and nonrefractory UC patients for active inflammation. Statistically significant differences were determined between groups, and tissues shown to have significant differences were further evaluated for their diagnostic performance. A total of 52 patients were included, 26 in each group. Significant differences were observed in intraepithelial neutrophil infiltration and percentage involvement of crypts/glands for the antrum, body, and duodenal bulb (P ≤ .001, .005, and .01 [intraepithelial neutrophil infiltration] and P = .001, .009, and .015 [% involvement], respectively). Microabscesses of mucosal glands/crypts were also experienced in a greater number of refractory UC patients in the stomach (ie, antrum and/or body of stomach; P = .005) and duodenum (ie, duodenum and/or duodenal bulb; P = .023). The sensitivity and specificity of upper GI tissues to predict refractory UC were moderate, with sensitivities ranging from 38% to 67% and specificities ranging from 81% to 100%. Our results suggest that children with refractory UC are more likely to have active inflammation in the upper GI tract, and thus, this may represent a predictor of responsiveness to current medical therapy.
More Related Videos
09:42Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
Published on: August 26, 2014
09:50Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
Published on: February 11, 2019
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: